Clinic
Scranton Hospital Company LLC
Scranton Hospital Company LLC was paid $4.28M by Medicaid between Nov 2019 and Dec 2024, across 136 billing codes. Its largest line is 99284, emergency room visit (serious) — 26% of everything it billed.
33Billing provider infoSCRANTON HOSPITAL COMPANY LLC
SCRANTON, PA 18510
SCRANTON, PA 18510
33aNPI1881983039assigned 03/28/2011
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$4.28M
24GClaims162,584
24DCodes billed136
24AFirst – last monthNov 2019 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Pennsylvania
Rank by total paid#8 of 119
Median peer was paid$57K
This provider vs. median75×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 149 | $2K | |
| 2020 | 11,224 | $217K | |
| 2021 | 46,972 | $1.13M | |
| 2022 | 26,261 | $706K | |
| 2023 | 49,982 | $1.38M | |
| 2024incomplete | 27,996 | $842K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 26% | 11,844 | 11,398 | $1.11M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 25% | 14,962 | 14,371 | $1.07M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.9% | 3,855 | 3,700 | $424K |
| G0378 | Hospital observation service, per hour | 4.4% | 195 | 192 | $189K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.6% | 937 | 910 | $153K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.5% | 4,972 | 4,747 | $151K |
| 80053 | Comprehensive metabolic panel | 3.2% | 15,241 | 14,545 | $138K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.9% | 5,202 | 4,939 | $126K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 16,821 | 15,863 | $78K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.7% | 437 | 207 | $71K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.5% | 1,216 | 1,178 | $64K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.4% | 1,294 | 1,270 | $59K |
124 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.1% | 6,456 | $49K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 2,062 | $45K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,097 | $41K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 619 | $34K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 476 | $33K |
| 71045 | Radiologic examination, chest; single view | <1% | 5,111 | $33K |
| 84484 | <1% | 4,650 | $33K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 3,030 | $32K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,922 | $29K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 316 | $25K |
| 81001 | <1% | 8,214 | $21K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 84 | $20K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,485 | $18K |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 384 | $16K |
| 83735 | <1% | 2,964 | $16K | |
| 83690 | <1% | 2,832 | $12K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 638 | $11K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,742 | $11K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 442 | $10K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 61 | $10K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 289 | $9K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 689 | $7K |
| 83880 | <1% | 347 | $7K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,115 | $7K |
| 87807 | <1% | 449 | $6K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 200 | $6K |
| 80061 | Lipid panel | <1% | 536 | $6K |
| 85610 | <1% | 1,918 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,223 | $5K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 94 | $5K |
| 85730 | <1% | 988 | $4K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 29 | $4K |
| 83605 | <1% | 753 | $4K | |
| 84703 | <1% | 401 | $4K | |
| 81025 | <1% | 1,239 | $4K | |
| 87040 | <1% | 365 | $4K | |
| 84100 | <1% | 805 | $4K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 71 | $3K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 107 | $3K |
| 80050 | General health panel | <1% | 66 | $3K |
| 85379 | <1% | 309 | $3K | |
| 84702 | <1% | 151 | $2K | |
| 85027 | <1% | 381 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 73 | $2K |
| 93971 | <1% | 39 | $2K | |
| 84439 | <1% | 304 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 341 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 327 | $2K |
| 86780 | <1% | 118 | $2K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 49 | $2K |
| 93017 | <1% | 39 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,503 | $1K |
| 86762 | <1% | 71 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 186 | $1K |
| 86803 | <1% | 70 | $1K | |
| 93970 | <1% | 16 | $1K | |
| 72100 | <1% | 73 | $1K | |
| 87070 | <1% | 206 | $1K | |
| 87077 | <1% | 153 | $1K | |
| 73030 | <1% | 73 | $926.52 | |
| 82550 | <1% | 190 | $921.72 | |
| 86850 | <1% | 132 | $883.45 | |
| 87186 | <1% | 155 | $824.20 | |
| 73630 | <1% | 90 | $821.34 | |
| 82962 | <1% | 718 | $766.60 | |
| 71250 | <1% | 14 | $681.31 | |
| 86901 | <1% | 203 | $654.47 | |
| 86900 | <1% | 203 | $651.01 | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 12 | $627.78 |
| 74018 | <1% | 41 | $566.15 | |
| 76830 | Ultrasound, transvaginal | <1% | 15 | $544.10 |
| 82077 | <1% | 133 | $540.04 | |
| 82607 | <1% | 58 | $533.43 | |
| J3490 | Unclassified drugs | <1% | 650 | $516.95 |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 14 | $500.58 |
| 97116 | <1% | 103 | $498.09 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,919 | $488.61 |
| J2704 | Injection, propofol, 10 mg | <1% | 2,693 | $463.54 |
| 88312 | <1% | 16 | $461.26 | |
| 86140 | <1% | 183 | $452.45 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 14 | $310.75 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 14 | $310.75 |
| 97161 | <1% | 13 | $292.60 | |
| 90715 | <1% | 50 | $290.18 | |
| 85651 | <1% | 110 | $268.37 | |
| 73610 | <1% | 15 | $259.43 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 39 | $220.81 |
| 73560 | <1% | 13 | $158.44 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,900 | $150.62 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 326 | $149.80 |
| 73130 | <1% | 13 | $125.96 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 15 | $124.74 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 445 | $123.33 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 971 | $121.51 |
| 83540 | <1% | 17 | $118.88 | |
| 82150 | <1% | 26 | $107.47 | |
| 82728 | <1% | 12 | $92.04 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,613 | $87.70 |
| 87147 | <1% | 30 | $80.20 | |
| 82043 | <1% | 15 | $80.03 | |
| C1769 | Guide wire | <1% | 14 | $76.14 |
| 82248 | <1% | 14 | $72.45 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,083 | $72.27 |
| 82570 | <1% | 14 | $64.06 | |
| 99152 | <1% | 14 | $54.47 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 71 | $47.14 |
| 83550 | <1% | 12 | $43.60 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 112 | $41.40 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 350 | $40.75 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 87 | $37.64 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 471 | $33.31 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 40 | $31.08 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,837 | $28.22 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 78 | $21.77 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 44 | $11.24 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 27 | $1.89 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 204 | $0.00 |
| 97165 | 0% | 12 | $0.00 | |
| 97535 | Self-care/home management training, each 15 minutes | 0% | 14 | $0.00 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 0% | 12 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 31 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 77 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 33 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.